pf-05230907
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2013 (NCT01897142)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Coagulation factor XSupplementation
F10 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4650415 ↗
- ChEMBLCHEMBL2108148 ↗
Also known as
- pf-05230907
- tachostyptan
- thromboplastin
- thromboplastin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02687191 | Phase 1 | Nov 26, 2016 | Pfizer |
| NCT02537002 | Phase 1 | Sep 1, 2015 | Pfizer |
| NCT01897142 | Phase 1 | Sep 1, 2013 | Pfizer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 3 | 3 | 1 | 2013 |
1 organizations
Page 1 / 1